Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2019

Oct 28, 2019

29745_dirs_2019-10-28_4fed18cd-f972-48db-b2f2-b18613f72784.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2019-10-25

Reporting Person: White Anne E. (SVP & Pres-Lilly Oncology)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-10-25 Common Stock P 1000 $108.84 Acquired 22043 Direct